Marc C A Stuart Selected Research

BPC194

1/2013

Dual action of BPC194: a membrane active peptide killing bacterial cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marc C A Stuart Research Topics

Disease

2	Rupture 01/2013 - 05/2005
1	Endophthalmitis (Ophthalmia) 02/2022
1	Dehydration (Water Stress) 02/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2019
1	Neoplasms (Cancer) 01/2019
1	Skin Diseases (Skin Disease) 03/2016
1	Psoriasis (Pustulosis Palmaris et Plantaris) 03/2016
1	Lung Neoplasms (Lung Cancer) 05/2015
1	Inflammation (Inflammations) 01/2015

Drug/Important Bio-Agent (IBA)

2	Liposomes (Liposome)IBA 02/2022 - 03/2016
2	Small Interfering RNA (siRNA)IBA 03/2016 - 01/2015
1	Moxifloxacin (Avelox)FDA Link 02/2022
1	L 377202IBA 01/2019
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019
1	Peptides (Polypeptides)IBA 01/2019
1	ProdrugsIBA 01/2019
1	beta-DefensinsIBA 03/2016
1	Biological ProductsIBA 05/2015
1	Surface-Active Agents (Surfactants)IBA 05/2015
1	Antimicrobial PeptidesIBA 01/2013
1	BPC194IBA 01/2013
1	SAINT 2IBA 05/2005
1	tesmilifene (DPPE)IBA 05/2005

Therapy/Procedure

1	Therapeutics 02/2022
1	Fluid Therapy (Oral Rehydration Therapy) 02/2022
1	Castration 01/2019
1	RNAi Therapeutics 03/2016